首页> 外文期刊>Nanotechnology >Galactosylated magnetic nanovectors for regulation of lipid metabolism based on biomarker-specific RNAi and MR imaging
【24h】

Galactosylated magnetic nanovectors for regulation of lipid metabolism based on biomarker-specific RNAi and MR imaging

机译:半乳糖基化磁性纳米载体可基于生物标记物特异性RNAi和MR成像调节脂质代谢

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The specific delivery of ribonucleic acid (RNA) interfering molecules to disease-related cells is still a critical blockade for in vivo systemic treatment. Here, this study suggests a robust delivery carrier for targeted delivery of RNA-interfering molecules using galactosylated magnetic nanovectors (gMNVs). gMNVs are an organic-inorganic polymeric nanomaterial composed of polycationics and magnetic nanocrystal for delivery of RNA-interfering molecules and tracking via magnetic resonance (MR) imaging. In particular, the surface of gMNVs was modified by galactosylgluconic groups for targeted delivering to asialoglycoprotein receptor (ASGPR) of hepatocytes. Moreover, the small interfering RNAs were used to regulate target proteins related with low-density lipoprotein level and in vivo MR imaging was conducted for tracking of nanovectors. The obtained results show that the prepared gMNVs demonstrate potential as a systemic theragnostic nanoplatform for RNA interference and MR imaging.
机译:核糖核酸(RNA)干扰分子向疾病相关细胞的特异性传递仍然是体内全身治疗的关键障碍。在这里,这项研究建议使用半乳糖基化的磁性纳米载体(gMNV)靶向RNA干扰分子的有力交付载体。 gMNV是由聚阳离子和磁性纳米晶体组成的有机-无机聚合物纳米材料,用于递送RNA干扰分子并通过磁共振(MR)成像进行跟踪。特别地,gMNV的表面被半乳糖基葡萄糖基修饰,以靶向递送至肝细胞的去唾液酸糖蛋白受体(ASGPR)。此外,小的干扰RNA被用来调节与低密度脂蛋白水平有关的靶蛋白,并在体内进行MR成像以追踪纳米载体。获得的结果表明,制备的gMNVs具有作为RNA干扰和MR成像的全身性鼻窦炎纳米平台的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号